Lipoprotein(a) [Lp(a)]: Reference Ranges, Risk, and What to Do About It

What Is Lipoprotein(a)?

If your cholesterol panel looked fine but heart disease still runs in your family, lipoprotein(a) may be part of the reason. Written Lp(a) and spoken as “L-P-little-a,” it is a specialized cholesterol-carrying particle in your blood. It looks a lot like LDL (low-density lipoprotein) cholesterol, with one important difference: an extra protein called apolipoprotein(a) is attached to it. That addition makes Lp(a) both more atherogenic (more likely to build plaque) and more prothrombotic (more likely to form clots) than ordinary LDL.

What sets Lp(a) apart is that it is largely genetically determined. Your level is set mostly by the LPA gene you inherit, stays fairly steady across your lifetime, and barely changes with diet, exercise, or weight loss. In other words, it is an inherited cardiovascular risk factor you can carry without any symptoms, and it does not show up on a standard cholesterol panel.

Reference Ranges and How Lp(a) Is Measured

Lp(a) can be reported in two different ways, and this trips up a lot of people. Some labs report it as a mass concentration in mg/dL, while others report it as a particle concentration in nmol/L. The nmol/L (molar) measurement is generally considered more accurate because Lp(a) particle size differs from person to person, which can throw off mass-based readings. The two units do not convert with a single fixed factor, so compare your results within the same unit system whenever you can.

Thresholds often used in practice include:

• Lower risk: below about 30 mg/dL (roughly <75 nmol/L)
• Borderline / intermediate: about 30–50 mg/dL (roughly 75–125 nmol/L)
• Elevated, tied to higher cardiovascular risk: above about 50 mg/dL (roughly >125 nmol/L)

These cut points depend on the assay and vary between laboratories, so always read your value against the specific reference range printed on your own report. Because Lp(a) is so genetically stable, most people need it measured only once in a lifetime, unless a new therapy or clinical situation calls for a recheck.

Symptoms, and Who Should Be Tested

Elevated Lp(a) causes no symptoms on its own. It stays silent until it contributes to a clinical event such as a heart attack, stroke, peripheral artery disease, or calcific aortic valve stenosis. That is why the only way to know your level is to test for it.

Testing is especially worth discussing with your clinician if any of these apply to you:

• A personal history of premature cardiovascular disease (a heart attack, stroke, or stent at a younger-than-expected age)
• A family history of early heart disease, or a known elevated Lp(a) in a close relative
• Familial hypercholesterolemia, or otherwise unexplained high LDL
• Cardiovascular events that happened despite well-controlled LDL cholesterol
• A wish for a more complete, longevity-focused cardiovascular risk assessment

Many professional guidelines now support measuring Lp(a) at least once in adults as part of a thorough cardiovascular risk evaluation, precisely because it is common, inherited, and otherwise invisible.

What Optimization Looks Like

Because Lp(a) itself responds little to lifestyle changes, the goal with an elevated level is to reduce your overall cardiovascular risk rather than chase the Lp(a) number alone. A practical, evidence-based approach usually includes:

• Aggressively controlling the risk factors you can change: optimizing LDL cholesterol, blood pressure, blood sugar, and inflammation, since a person with high Lp(a) benefits from keeping every other risk factor as low as possible.
• Not smoking, and maintaining a heart-healthy diet, regular physical activity, and healthy body composition. These support your heart broadly even though they do not move Lp(a) much.
• LDL-lowering therapy where appropriate, guided by your clinician. (Statins do not meaningfully lower Lp(a), but they remain a cornerstone of overall risk reduction.)
• Cascade screening of family members, since elevated Lp(a) is inherited and finding it in relatives can prompt earlier preventive care.

Several Lp(a)-specific lowering therapies are in active clinical development, but none has yet been established as standard-of-care to reduce events. Any treatment decision should be individualized with a licensed clinician who can weigh your complete risk profile.

Understanding Your Number

A single Lp(a) test adds a meaningful, lifelong piece to your cardiovascular picture, something a standard lipid panel cannot give you. For patients in Louisville and across Kentucky pursuing preventive and longevity-focused care, knowing your Lp(a) helps your care team personalize how intensively to manage every other risk factor.

Educational only, not medical advice; consult a licensed clinician. Reference ranges are assay-dependent and individual interpretation requires a qualified physician who knows your full history.

Start your ENNU Life health assessment to take the first step toward understanding your cardiovascular and longevity risk profile.